Telaprevir Open-Label Study in Co-Infected Patients

Clinical trial NCT01500616 · COMPLETED

Trial details

NCT number: NCT01500616
Sponsor: Janssen-Cilag International NV
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2012-06-01
Primary completion: 2014-08-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.